Evidence map›Paper›PMID 39313675›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Effects of intranasal oxytocin on fear extinction learning.

Mahmoud Rashidi, Joe J Simon, Katja Bertsch, Gerhard Vincent Wegen, Beate Ditzen, Herta Flor, Valery Grinevich, Robert Christian Wolf, Sabine C Herpertz

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mahmoud RashidiDepartment of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany. rashidi.19@osu.edu.ORCID 0000-0002-9925-4988
Joe J SimonDepartment of General Internal Medicine and Psychosomatics, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.
Katja BertschDepartment of Psychology, Julius Maximilians University of Wuerzburg, Wuerzburg, Germany.
Gerhard Vincent WegenDepartment of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.
Beate DitzenInstitute of Medical Psychology, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.
Herta FlorInstitute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0003-4809-5398
Valery GrinevichDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-6337-8866
Robert Christian Wolf *Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-5358-5212
Sabine C Herpertz *Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Once a threat no longer exists, extinction of conditioned fear becomes adaptive in order to reduce allotted resources towards cues that no longer predict the threat. In anxiety and stress disorders, fear extinction learning may be affected. Animal findings suggest that the administration of oxytocin (OT) modulates extinction learning in a timepoint-dependent manner, facilitating extinction when administered prior to fear conditioning, but impairing it when administered prior to extinction learning. The aim of the present study was to examine if these findings translate into human research. Using a randomized, double-blind, placebo-controlled, 2-day fear conditioning and extinction learning design, behavioral (self-reported anxiety), physiological (skin conductance response), neuronal (task-based and resting-state functional magnetic resonance imaging), and hormonal (cortisol) data were collected from 124 naturally cycling (taking no hormonal contraceptives) healthy females. When administered prior to conditioning (Day 1), OT, similar to rodent findings, did not affect fear conditioning, but modulated the intrinsic functional connectivity of the anterior insula immediately after fear conditioning. In contrast to animal findings, OT impaired, not facilitated, extinction learning on the next day and increased anterior insula activity. When administered prior to extinction learning (day 2), OT increased the activity in the bilateral middle temporal gyrus, and similar to animal findings, reduced extinction learning. The current findings suggest that intranasal OT impedes fear extinction learning in humans regardless of the timepoint of administration, providing new insights and directions for future translational research and clinical applications.

Indexed as

Conditioning, ClassicalExtinction, PsychologicalFearOxytocinAdministration, IntranasalAdolescentAdultDouble-Blind MethodFemaleGalvanic Skin ResponseHumansHydrocortisoneMagnetic Resonance ImagingYoung AdultHydrocortisoneOxytocin

Identifiers

PMID39313675
PMCPMC11735929

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.